









Markets
/
Stocks
/
nasdaq-sint
/

SINTX Technologies Inc

SINT

3.360USD

+0.150+4.67%

Market hours （ET）Quotes delayed by 15 min

8.36MMarket Cap

LossP/E TTM



SINTX Technologies Inc

3.360

+0.150+4.67%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of SINTX Technologies Inc

Currency: USD Updated: 2025-11-04

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company shows very weak stock market performance, in line with its fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SINTX Technologies Inc's Score

Industry at a Glance

Industry Ranking

148 / 210

Overall Ranking

368 / 4616

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

25.000

Target Price

+648.50%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SINTX Technologies Inc Highlights

StrengthsRisks

SINTX Technologies, Inc. is an advanced ceramics company. The Company is focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. The Company is focusing primarily on the research, development and commercialization of medical devices manufactured with silicon nitride. The Company is manufacturing, research, and development of products comprised from advanced ceramic materials for external partners. It produces silicon nitride for use in its commercial products and product candidates in various forms: solid silicon nitride, porous silicon nitride, silicon nitride powder, composites of silicon nitride and PEEK and PEKK and silicon nitride coating. It is also focused on development and manufacturing ceramics for personnel, aircraft, and vehicle armor. Its silicon nitride products can be polished to a smooth and wear-resistant surface for articulating applications, such as bearings for hip and knee replacements.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 84.95% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 2.89M.

Undervalued

The company’s latest PE is -0.38, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 265.94K shares, increasing 14.69% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 1.15K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-04

The company's current financial score is 5.60, which is lower than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 151.00K, representing a year-over-year decrease of 82.42%, while its net profit experienced a year-over-year decrease of 5.17%.

Score

Industry at a Glance

Previous score

5.60

Change



Financials

6.95

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.78

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.57

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

3.56

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.13

Key Metrics

Free cash flow

No Data

SINTX Technologies Inc's Company Valuation

Currency: USD Updated: 2025-11-04

The company’s current valuation score is 8.79, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is -0.38, which is -97.33% below the recent high of -0.01 and -102.54% above the recent low of -0.77.

Score

Industry at a Glance

Previous score

8.79

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 148/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-04

The company’s current earnings forecast score is 8.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for SINTX Technologies Inc is 25.00, with a high of 25.00 and a low of 25.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

25.000

Target Price

+648.50%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

SINTX Technologies Inc

SINT

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-04

The company’s current price momentum score is 1.51, which is lower than the Healthcare Equipment & Supplies industry's average of 6.77. Sideways: Currently, the stock price is trading between the resistance level at 4.22 and the support level at 2.61, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

1.43

Change

0.08

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.087

Sell

RSI(14)

39.585

Neutral

STOCH(KDJ)(9,3,3)

25.470

Neutral

ATR(14)

0.378

Low Volatility

CCI(14)

-94.567

Neutral

Williams %R

87.755

Oversold

TRIX(12,20)

-1.000

Sell

StochRSI(14)

40.230

Sell

Moving Average

Sell(4)

Neutral(0)

Buy(2)

Indicators

Value

Direction

MA5

3.292

Buy

MA10

3.401

Sell

MA20

3.722

Sell

MA50

4.119

Sell

MA100

3.572

Sell

MA200

3.262

Buy

Institutional Confidence

Currency: USD Updated: 2025-11-04

The company’s current institutional recognition score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 6.39. The latest institutional shareholding proportion is 8.16%, representing a quarter-over-quarter decrease of 54.20%. The largest institutional shareholder is The Vanguard, holding a total of 30.43K shares, representing 0.85% of shares outstanding, with 5138.27% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Medtech Ceramics LP

250.08K

Murphy (Kevin Patrick)

138.96K

Veracity Capital LLC

72.46K

Honigblum (Gregg R.)

77.26K

+183.45%

Citadel Advisors LLC

35.11K

Olson Eric K

39.02K

+36.70%

The Vanguard Group, Inc.

Star Investors

30.43K

Geode Capital Management, L.L.C.

15.34K

+33.49%

Anderson (Mark Lewis)

15.00K

Risk Assessment

Currency: USD Updated: 2025-11-04

The company’s current risk assessment score is 1.67, which is lower than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 0.67. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.